1.
2.
Artículo
en Inglés
| IMSEAR
| ID: sea-64955
RESUMEN
Intravesical bacillus Calmette-Guerin (BCG) is used in patients with urinary bladder carcinoma. Although it is generally well tolerated, granulomatous hepatitis is a rare but serious complication. We report a 42-year-old man and a 56-year-old man who developed granulomatous hepatitis following intravesical BCG. One of them was treated successfully with antitubercular therapy; the other died because of BCG sepsis and multi-organ failure.
Asunto(s)
Administración Intravesical , Adulto , Antituberculosos/uso terapéutico , Vacuna BCG/efectos adversos , Biopsia con Aguja , Carcinoma de Células Transicionales/tratamiento farmacológico , Resultado Fatal , Humanos , Hígado/microbiología , Masculino , Persona de Mediana Edad , Tuberculosis Hepática/tratamiento farmacológico , Neoplasias de la Vejiga Urinaria/tratamiento farmacológico
3.
Artículo
en Inglés
| IMSEAR
| ID: sea-65171